Navigation Links
China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010
Date:5/19/2010

FEICHENG, China, May 19 /PRNewswire-Asia-FirstCall/ -- China Ruitai International Holdings Co., Ltd. ("China Ruitai," "TaiAn" or the "Company") (OTC Bulletin Board: CRUI), a manufacturer and distributor of cellulose ether additives for use in the production of pharmaceuticals, construction materials, PVC products, foods and beverages and cosmetics, today announced financial results for its first quarter ended March 31, 2010.

    First Quarter 2010 Highlights
    -- Q1 revenue increased 24.4% to $10.2 million
    -- Q1 net income increased 35.7% to $1.9 million
    -- Q1 EPS of $0.07 vs. $0.05

    First Quarter 2010 Results
                                Q1 2010              Q1 2009          CHANGE
    Net Sales                $10.2 million         $8.2 million       +24.4%
    Gross Profit             $3.30 million        $3.25 million        +1.7%
    Net Income
     attributable to China
     Ruitai International
     Holding Co., Ltd.        $1.9 million         $1.4 million       +38.6%
    Earnings Per Share           $0.07                $0.05           +40.0%

Company Overview and First Quarter 2010 Results

China Ruitai is one of the largest manufactures of non-ionic cellulose ether products in China. Specifically, cellulose either is an organic chemical derived from cotton that serves as a thickener and stabilizer for a wide variety of commercial industries and products, including pharmaceuticals, construction materials, petrochemicals, food and beverage products, in addition to cosmetics. Specifically, the Company's cellulose ether is a stabilizer and thickener in latex paint and dry mix for concrete mortar and, used as a membrane reagent in pharmaceuticals, and a thickener and binding agent
'/>"/>

SOURCE China Ruitai International Holdings Co., Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. China Sky One Medical Announces First Quarter 2010 Results
2. Dehaier Medical Systems Announces New Exclusive China Distribution Agreement with Welch Allyn, Further Broadening Companys Product Lines
3. China Biologic Products Announces First Quarter 2010 Results
4. China Sky One Medicals CEO Receives Award For "Leadership Excellence In Innovation"
5. China Sky One Medical to Attend Investment Conferences in May
6. China Biologic Products to Build Two New Plasma Stations in Shandong Province
7. China Nepstar Chain Drugstore Reschedules First Quarter 2010 Results to May 18
8. China Yongxin Pharmaceuticals is Selected as one of the Qualified Pharmaceutical Distributors for Jilin Province
9. China Pharma Holdings, Inc. Announces May Investor Conference Participation
10. China Nepstar Chain Drugstore Reports First Quarter 2010 Results on May 19
11. China Medical Technologies to Announce Results for the Fourth Fiscal Quarter and the Fiscal Year Ended March 31, 2010 on June 4, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... , December 15, 2014 Investor-Edge has ... ZGNX ), Eli Lilly and Company (NYSE: ... (NYSE: SNY ), and Novartis AG (NYSE: ... be accessed at: http://investor-edge.com/register . On Friday, ... 1.16%, the Dow Jones Industrial Average lost 1.79%, to finish ...
(Date:12/15/2014)... and BOSTON , December 15, 2014 ... structure-guided drug discovery and development company, is pleased to ... the United States relating to its ... in the US significantly strengthens the global patent estate ... markets. The suite of patents recently granted ...
(Date:12/13/2014)... HUNTSVILLE, Ala. , Dec. 12, 2014 /PRNewswire-USNewswire/ ... has purchased the HiSeq X Ten sequencing system ... will enable HudsonAlpha to produce and analyze genomic ... purchase stems from the Institute,s commitment to research ... The HiSeq X Ten provides unprecedented capacity, ...
Breaking Medicine Technology:Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 3Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 4Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 5Heptares Extends Global Patent Protection for GPCR-Focused Drug Discovery Platform With Grant of Core Patents in the United States 2HudsonAlpha announces purchase of Illumina HiSeq X Ten sequencing system 2HudsonAlpha announces purchase of Illumina HiSeq X Ten sequencing system 3
... InterMune, Inc. (Nasdaq: ITMN ) today ... development program for pirfenidone and idiopathic pulmonary fibrosis (IPF) ... European Respiratory Society (ERS), to be held September 18-22 ... Executive Officer and President of InterMune, said, "We are ...
... Soligenix, Inc. (Soligenix or the Company) (OTC Bulletin ... announced today that its President and Chief Executive Officer ... highlighting recent developments at the Rodman & Renshaw 12th ... will take place on Wednesday, September 15, 2010 at ...
Cached Medicine Technology:InterMune Announces Four Oral Presentations on Pirfenidone and IPF at the Annual Congress of the European Respiratory Society (ERS) 2InterMune Announces Four Oral Presentations on Pirfenidone and IPF at the Annual Congress of the European Respiratory Society (ERS) 3InterMune Announces Four Oral Presentations on Pirfenidone and IPF at the Annual Congress of the European Respiratory Society (ERS) 4InterMune Announces Four Oral Presentations on Pirfenidone and IPF at the Annual Congress of the European Respiratory Society (ERS) 5Soligenix to Present at the Rodman & Renshaw Healthcare Conference on September 15, 2010 at 10AM EDT 2Soligenix to Present at the Rodman & Renshaw Healthcare Conference on September 15, 2010 at 10AM EDT 3
(Date:12/17/2014)... Dr. Myo Nwe is the co-author of a new ... and co-founder of the Ace Medical Weight Loss Center in ... broad look at the industry of weight loss, and how ... film and in television shows, however, she says the topic ... and played for basic laughs, which she believes impacts whether ...
(Date:12/17/2014)... 17, 2014 This prestigious award ... that have made outstanding and innovative contributions to ... progression of private practice physical therapy by the ... Association. , On behalf of Performance Physical Therapy, ... CEO of Performance accepted the award at the ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 A group of ... for Longevity, today, in reaction to a recent statement by ... of brain training and derogated the efficacy of all brain ... agreed with the parts of the center’s statement critical of ... the center had also overstated its case, in a document ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 No matter ... been able to eradicate the head louse parasite—a common ... for parents. Each year between six and twelve million ... the Miami-based lice removal treatment company comes to the ... and environmentally friendly. With its track record of customer ...
(Date:12/17/2014)... Project Veritas is releasing a video ... MIT economist and Obamacare architect Jonathan Gruber to public ... the interview, which is being distributed on YouTube. , ... mislabeling in the Affordable Care Act in order to ... billion dollar per year tax grab. , “President Obama ...
Breaking Medicine News(10 mins):Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2Health News:Performance Physical Therapy Awarded with Jayne L. Snyder Private Practice of the Year 2014 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 4Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2
... which was just approved for treating leukemia, also shows promise ... Drug Administration approved the use of a promising anti-leukemia drug ... The drug, Gleevec, administered as a pill once a day, ... its ability to target and kill cancer cells without attacking ...
... study on a vaccine made from the immune system ... a promising. Dr. Johannes Vieweg, associate professor of urology ... Medical Center in Durham, tested the vaccine on 13 ... uses the men's own dendritic cells, extracted white blood ...
... native to the South Sea Islands. It is a herb ... diseases. The herb is commonly used by consumers as a ... spasms. According to experts, the herb behaves like a class ... ,Benzodiazepines have been shown to be habit-forming when taken ...
... a person's face could unveil whether he or she is ... non smokers.A study by dermatologists, published in The Lancet, shows ... that breaks down collagen in the skin.// ,Collagen is ... elasticity of the skin. When this starts to deteriorate, skin ...
... Doctors investigating a theory that contemporary orgasms succor fertility found ... from their partners than those that did not. The best ... with your partner, scientists have ascertained. ,Dr Cathy, from ... with an average age of 32. //The women were asked ...
... best foot forward in completing its social responsibility. ... Zyban, its anti-smoking drug. Glaxo is aiding companies ... policy, along with providing teams to help in ... corporate, which have negotiated for this 'no-smoking' environment, ...
Cached Medicine News:
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: